Lung Cancer Surgery Market Report

Lung Cancer Surgery Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR1036

Rising air pollution levels coupled with increasing number of cigarette smokers are amongst key factors attributing for increasing prevalence of lung cancer which inturn is expected to give rise to lung cancer surgery market during the forecast period. According to estimates published by American Association for Thoracic Surgery lung cancer was leading cause of cancer deaths in U.S. in 2012. Increasing global incidence of lung cancer is a primary factor pushing growth of this market. 

Lung cancer surgery market is studied with respect to two segments such as products and type of surgeries. Product segment of lung cancer surgery is further segmented in to four types as surgical devices, endosurgical equipment and monitoring or visualizing equipment. Types of surgery segment is further subdivided in to robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery and endobronchial surgery. Thoracotomy is extensively used surgical process for the treatment of lung cancer thereby attributing the largest market share in 2013. Thoracotomy also includes lobectomy or pneumonectomy which is used as lung cancer treatment. With advent of technological advancements in the field of automation robotic surgeries are also gaining popularity and acceptance amongst healthcare professionals for surgical procedures. Robotic surgeries are minimally invasive in nature thereby providing comfort to the patients. However, comparatively expensive nature of robotic surgeries can act as a hurdle in emerging economies of Asia Pacific region such as India and China. 

On the basis of geography the market is segmented as North America, Europe, Asia Pacific and RoW. North American market with virtue of higher prevalence rate of lung cancer coupled with advanced healthcare infrastructure supporting technologically advanced surgeries such as robotic surgery has emerged as most mature market. Furthermore, Asia pacific is expected to be most lucrative market owing to the rapidly developing healthcare infrastructure, increasing patient awareness levels and acceptance of technologically developed robotic surgeries in the Japan and emerging economies of India and China. 

The lung cancer surgery market has few prominent players investing majorly on R&D. Prominent players studied in this market include Accuray Inc., BSD Medical Corp., Covidien, Angiodynamics, Richard Wolf GMBH, Siemens Healthcare, Olympus Corp., Neomend Inc., Ethicon Endo surgery Inc., Teleflex, Trokamed GMBH and Scanlan International Inc.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA